BDBM519360 (4S,5R)-N-(2,3- dihydro-1,4- benzodioxin-5- ylmethyl)-5-[3-fluoro- 5- (trifluoromethyl)phenyl]- 4-methyl-2-oxo-1,3- oxazolidine-3- carboxamide::US11141410, Example 11

SMILES C[C@H]1[C@H](OC(=O)N1C(=O)NCc1cccc2OCCOc12)c1cc(F)cc(c1)C(F)(F)F

InChI Key InChIKey=WPTFJZWWXARSNL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 519360   

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM519360((4S,5R)-N-(2,3- dihydro-1,4- benzodioxin-5- ylmeth...)
Affinity DataIC50: 50nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
Go to US Patent